Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | CES1 | P23141 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Boric Acid SCHEMBL28454768 | 1.00 | ANPEP (0.43) | ANPEPALDH1A1SMN1; SMN2TSHRLMNA | |
| SCHEMBL153638 | 0.87 | TSHR (0.46) | ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10 | |
| SCHEMBL704491 | 0.83 | TSHR (0.43) | ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10 | |
| SCHEMBL10423271 | 0.83 | TSHR (0.43) | ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10 | |
| Fluoride SCHEMBL27639893 | 0.83 | TSHR (0.43) | ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10 | |
| SCHEMBL702940 | 0.83 | TSHR (0.43) | ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10 | |
| Hydrochloric Acid SCHEMBL2140790 | 0.83 | TSHR (0.43) | ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10 | |
| SCHEMBL706848 | 0.83 | TSHR (0.43) | ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10 | |
| Bromide SCHEMBL31547794 | 0.83 | TSHR (0.43) | ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10 | |
| SCHEMBL28217587 | 0.83 | TSHR (0.43) | ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110611121-B | Electrolyte and lithium ion battery containing same | 宁德时代新能源科技股份有限公司 | 2021-06-22 | — | — | CN | claimed |
| CN-110611121-A | Electrolyte and lithium ion battery containing same | 宁德时代新能源科技股份有限公司 | 2019-12-24 | — | — | CN | claimed |
| CN-109768326-A | Electrolyte and electrochemical energy storage device | 宁德时代新能源科技股份有限公司 | 2019-05-17 | — | — | CN | claimed |
| US-11581567-B2 | Lithium ion battery and electrolyte thereof | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2023-02-14 | — | — | US | disclosed |
| CN-110611121-B | Electrolyte and lithium ion battery containing same | 宁德时代新能源科技股份有限公司 | 2021-06-22 | — | — | CN | disclosed |
| CN-110611121-A | Electrolyte and lithium ion battery containing same | 宁德时代新能源科技股份有限公司 | 2019-12-24 | — | — | CN | disclosed |
| CN-109768326-A | Electrolyte and electrochemical energy storage device | 宁德时代新能源科技股份有限公司 | 2019-05-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11581567-B2 | Lithium ion battery and electrolyte thereof | PLCB1, PLCB3, LAGE3 | ANPEP 1739/4885ALDH1A1 4709/4885SMN1; SMN2 3384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.